Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • San Antonio Breast Cancer Symposium in Texas

Weight loss may minimize breast cancer risk in postmenopausal women

    • Congress Reports
    • Gynecology
    • Oncology
    • RX
    • Studies
  • 3 minute read

Breast cancer remains the most common cancer in women and accounts for approximately one in five cancer-associated deaths. Regarding the relationship between weight loss and breast cancer risk, a study now provided insight at the San Antonio Breast Cancer Symposium in Texas.

Breast cancer remains the most common cancer in women. Despite ever-improving therapy and steady declines in death rates since 1985, breast carcinoma continues to account for approximately one in five cancer-associated deaths [2]. Effective primary prevention is therefore of great importance. Prof. Rowan Chlebowski, M.D., Department of Medical Oncology and Therapeutics Research at the City of Hope in Duarte, California, USA, presented an analysis of data from the Women’s Health Initiative (WHI) Observational Study at the San Antonio Breast Cancer Symposium that provided positive results on the topic.

Women’s Health Initiative (WHI) Observational Study

The WHI Observational Study included 93 676 postmenopausal women aged 50 to 79 years. Participants were recruited at 40 different centers across the United States between 1993 and 1998. Exclusion occurred, among other things, when a disease was present that made an average life expectancy of three years unlikely. The aim of the study was to explore predictors and triggers of morbidity and mortality in postmenopausal women as well as to act as a control for the WHI clinical trial [3].

If there was evidence of an unremarkable mammogram, a negative medical history for the presence of breast carcinoma, and a BMI ≥18.5 kg/m2, the data of the respective subjects were included in the current evaluation by Prof. Chlebowski. At the beginning of the study and after three years, the height and weight of the subjects were recorded.

Chlebowski’s study

The final cohort used for Prof. Chlebowski’s evaluation consisted of 61 335 women [4]. 41% were normal weight at baseline, 34% overweight, and 25% obese.

A follow-up was conducted after three years. Weight trends were evaluated and women were categorized as having “weight stability” (≤5% change in weight, n=41,139), having “gained weight” (≥5% increase, n=12,021), and having “lost weight” (≥5% decrease, n=8175). The limit value was set at 5%, since a decrease of min. 5% weight could influence certain biochemical processes in the body that are suspected to be associated with cancer, the authors of the study said. In addition to monitoring weight history, questionnaires regarding medical history, medication, risk factors for breast cancer, and mammography frequency were also collected.

Effects of moderate weight loss

For evaluation, subjects were divided into four groups and their data were analyzed according to tumor subtype (hormone receptor and Her2/neu status), baseline BMI (normal, overweight, obese), age (50-<70 years), and ethnicity. There was no difference between the groups in this respect.

Over a median follow-up period of 11.4 years, during which women were screened annually for breast cancer, 3061 of the total 61,335 patients developed invasive breast cancer. This showed that compared to those subjects with a stable weight history, women who had lost ≥5% weight had a 12% reduced likelihood of developing breast cancer (HR=0.88, p=0.02). If weight loss of ≥15% had occurred, the risk was reduced by 37% (HR=0.63). There was no significant difference in breast cancer incidence and unintentional or intentional weight loss (HR=0.82 vs. 0.91, p=0.2).

Although weight gain (≥5%) was not associated with an overall higher risk of developing breast cancer (HR=1.02), women in this category had a greater than 50% increased risk of triple-negative breast cancer (HR=1.54).

Parallels in endometrial cancer

Similar results have been shown for endometrial carcinoma [5]. Postmenopausal women who lost ≥5% had a significantly lower risk of developing endometrial cancer compared with those with stable weight (HR=0.71). The clearest association was among obese women with intentional weight loss (HR=0.44).

Source: San Antonio Breast Cancer Symposium, December 5-9, 2017, San Antonio.

Literature:

  1. Swiss Federal Statistical Office: Health Determinants: Overweight. www.bfs.admin.ch/bfs/de/home/statistiken/gesundheit/determinanten/uebergewicht.html (as of 12/15/17)
  2. Federal Statistical Office: Specific Cancer Diseases. www.bfs.admin.ch/bfs/de/home/statistiken/gesundheit/gesundheitszustand/krankheiten/krebs/spezifische.html (as of 12/15/17)
  3. Langer RD, et al: The Women’s Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 2003; 13 (9 Suppl): S107-21.
  4. San Antonio Breast Cancer Symposium (SABCS) 2017: Abstract GS5-07. Presented December 8th, 2017.
  5. Luo J, Hendryx M, Chlebowski RT: Intentional weight loss and cancer risk. Oncotarget 2017; 8(47): 81719-81720.

InFo ONCOLOGY & HEMATOLOGY 2018; 6(1): 27-28.

Autoren
  • Dr. med. Katrin Hegemann
Publikation
  • InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
  • Endometrial Cancer
  • Overweight
  • postmenopausal
  • rust crab
  • Weight loss
Previous Article
  • Sport and oncology

Staying active with a cancer diagnosis

  • General Internal Medicine
  • News
  • Oncology
  • Prevention and health care
  • RX
  • Sports Medicine
  • Studies
View Post
Next Article
  • Swiss Derma Day and STI reviews and updates, Lucerne

Inflammatory scalp diseases

  • Congress Reports
  • Dermatology and venereology
  • RX
View Post
You May Also Like
View Post
  • 2 min
  • Chronic pain

Nano-ECS modulator Adezunap improves therapy success

    • Congress Reports
    • General Internal Medicine
    • Pharmaceutical medicine
    • Pharmacology and toxicology
    • Phytotherapy
    • Rheumatology
    • RX
    • Studies
View Post
  • 8 min
  • Psoriasis and PsA

Biologics, oral peptide and trivalent nanobody – current results and trends

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • RX
    • Studies
View Post
  • 5 min
  • Cancer in Europe: facts and analysis

New Health Policy Report published

    • General Internal Medicine
    • Oncology
    • Practice Management
    • Prevention and health care
    • RX
    • Studies
View Post
  • 4 min
  • Gastrointestinal complaints

PPI regulation under the microscope

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 6 min
  • Wound management: clinical diagnostics

Assessing the risk of infection – from the ABCDE to the TILI score

    • Congress Reports
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Geriatrics
    • Infectiology
    • Interviews
    • Physical medicine and rehabilitation
    • Prevention and health care
    • RX
View Post
  • 4 min
  • Study report

Digital patient education for atrial fibrillation shows measurable effects

    • Cardiology
    • Education
    • General Internal Medicine
    • RX
    • Studies
View Post
  • 4 min
  • New practice guideline for fibromyalgia syndrome

Good times, bad times

    • Congress Reports
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Physical medicine and rehabilitation
    • Rheumatology
    • RX
    • Sports Medicine
    • Studies
View Post
  • 16 min
  • IBDmatters - Synergy effects for IBD pathways

How combination therapies lead to better treatment results

    • CME continuing education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Genetics
    • RX
    • Studies
    • Training with partner
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    How combination therapies lead to better treatment results
  • 2
    Interplay between cancer and mental illness
  • 3
    PH and lung diseases
  • 4
    Treatment of comorbidities in older people
  • 5
    Multidisciplinary teams in oncology

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.